Metsera Inc (MTSR)

NASDAQ
Currency in USD
39.28
+2.87(+7.88%)
Closed·
After Hours
39.00-0.31(-0.79%)
·
MTSR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week High
Fair Value
Day's Range
34.5340.47
52 wk Range
12.3040.47
Key Statistics
Edit
Prev. Close
39.28
Open
35.4
Day's Range
34.53-40.47
52 wk Range
12.3-40.47
Volume
937.6K
Average Volume (3m)
1.02M
1-Year Change
-
Book Value / Share
4.81
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MTSR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
55.00
Upside
+40.02%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Metsera Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Metsera Inc Company Profile

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York.

Compare MTSR to Peers and Sector

Metrics to compare
MTSR
Peers
Sector
Relationship
P/E Ratio
−15.5x−5.1x−0.5x
PEG Ratio
-0.000.00
Price/Book
8.2x2.7x2.6x
Price / LTM Sales
-235.4x3.2x
Upside (Analyst Target)
57.8%150.1%45.9%
Fair Value Upside
Unlock9.2%7.0%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 55.00
(+40.02% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-1.03 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MTSR Income Statement

People Also Watch

27.250
DFDV
+10.59%
15.05
MAZE
-3.77%
6.650
LIMN
-7.64%
6.480
SRM
-4.85%
40.62
BMNR
-11.71%

FAQ

What Is the Metsera (MTSR) Stock Price Today?

The Metsera stock price today is 39.28

What Stock Exchange Does Metsera Trade On?

Metsera is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Metsera?

The stock symbol for Metsera is "MTSR."

What Is the Metsera Market Cap?

As of today, Metsera market cap is 4.13B.

What Is Metsera's Earnings Per Share (TTM)?

The Metsera EPS (TTM) is -8.99.

When Is the Next Metsera Earnings Date?

Metsera will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is MTSR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Metsera Stock Split?

Metsera has split 0 times.

How Many Employees Does Metsera Have?

Metsera has 96 employees.

What is the current trading status of Metsera (MTSR)?

As of 13 July 2025, Metsera (MTSR) is trading at a price of 39.28, with a previous close of 39.28. The stock has fluctuated within a day range of 34.53 to 40.47, while its 52-week range spans from 12.30 to 40.47.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.